More on PLX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.13 |
|
|||
| Open | $1.12 | ||||
| 52 Wk High | $1.11 | ||||
| 52 Wk Low | $0.41 | ||||
| Day High | $1.17 | ||||
| Day Low | $1.10 | ||||
| P/E | N/A | ||||
| EPS | $-0.29 | ||||
| Volume | 449,804 | ||||
- Form 4 Protalix BioTherapeutics For: Apr 01 Filed by: Bashan Dror
- Form 10-K Protalix BioTherapeutics For: Dec 31
- Form 8-K Protalix BioTherapeutics For: Mar 14
- Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
- Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
- Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference
- Form SC 13G/A Protalix BioTherapeutics Filed by: NACHT MARIUS
- Form 8-K Protalix BioTherapeutics For: Dec 26
- Protalix BioTherapeutics (PLX) Issues 2024 Letter to Stockholders
- Protalix BioTherapeutics Issues 2024 Letter to Stockholders
Entities mentioned with PLX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Pre Market Movers | View Related Stories »
- Crude Oil | View Related Stories »
- UBS | View Related Stories »
- Show More...
